Skip to main content
Clinical Trials/CTRI/2023/06/054459
CTRI/2023/06/054459
Not Yet Recruiting
N/A

ASSESSMENT OF EFFICACY OF DAPAGLIFLOZIN IN PATIENTS OF LIVER CIRRHOSIS WITH DIABETES MELLITUS AS COMPARED TO STANDARD MEDICAL TREATMENT

Pt BD Sharma Institute of Medical Science, Rohtak0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Pt BD Sharma Institute of Medical Science, Rohtak
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Pt BD Sharma Institute of Medical Science, Rohtak

Eligibility Criteria

Inclusion Criteria

  • All Patients with liver cirrhosis having age 18years to 70years with Diabetes Mellitus requiring drug treatment. Patients who are willing to participate

Exclusion Criteria

  • Age \<18years or \>70years. Cerebrovascular disorder, any neurological disorder including dementia/Alzheimerâ??s etc.Pregnancy.Chronic kidney disease . Any malignancy excluding Hepatocellular Carcinoma .Patient who refused to give consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials